Immunization Newsbriefs (c) Copyright Information Inc.,

Bethesda, MD. Brought to you by the National Network for

Immunization Information (NNii). Visit NNii's new website at

http://www.immunizationinfo.org .

 

------------------------------------------------------------

 

U.S. IMMUNIZATION NEWS

 

"Herpes Simplex Viruses: Is a Vaccine Tenable?"

Journal of Clinical Investigation ( www.jci.org ) (07/01/02) Vol.

110, No. 2, P. 145; Whitley, Richard J.; Roizman, Bernard

 

Herpes simplex virus (HSV) has been documented since the era of

the ancient Greeks, yet there has not been developed a vaccine

for either HSV-1, which is commonly associated with oral lesions,

or HSV-2, which causes most genital lesions--a task made more

difficult by the disease's ability to lie dormant for a time and

reappear at a later date.  The disease is especially dangerous

because it can invade and replicate within the central nervous

system, but little is known about how herpes becomes latent,

reactivates, and moves into the nervous system.  In the United

States, some 100 million people are infected with HSV-1, while

between 40 million and 60 million people have HSV-2.  In causing

genital ulcerative disease, HSV increases the risk of contracting

HIV by a factor of three or more as well.  However, prior

infection with HSV-1 results in milder and less frequent episodes

of HSV-2, and animal models of HSV have effected the prevention

of HSV challenge through vaccination, two factors that suggest a

vaccine against HSV is possible.  Two vaccines in development

offer optimism in the fight against HSV: one employs

glycoproteins as subunit vaccines to attach to the virus in

combination with adjuvant, while the other is a genetically

engineered live, attenuated vaccine that has been altered to

remove its neurovirulence sequences.  Though the vaccines have

shown some efficacy in humans, clinical evaluations of HSV

vaccines have been lacking in methodology, providing inconclusive

evidence about the vaccines.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.